🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2025-02-14
Trial ID
NCT06819826
Treatments Being Tested
This is a Phase II, randomized, double-blind, placebo-controlled, multicent...
Status
Completed
Location
University of Arkansas For Medical Sciences
Start Date
2020-06-02
Trial ID
NCT04386616
Treatments Being Tested
This study was designed to assess the safety, tolerability and efficacy of ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT02007252
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
In Parkinson's disease (PD), there is inflammation in the brain, the gut an...
Status
Recruiting
Location
John Van Geest Centre for Brain Repair
Start Date
2026-02-02
Trial ID
NCT07157735
Treatments Being Tested
The study is designed to assess whether repeated dosing with CE-326,597 wil...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-01
Trial ID
NCT00576589
Treatments Being Tested
The purpose of this study is to determine whether treatment of unexplained ...
Status
Terminated
Location
Lakeview Medical Research
Start Date
2012-03
Trial ID
NCT01506726
Treatment for head and neck cancer often involves a combination of chemothe...
Status
Terminated
Location
Investigational Site
Start Date
2015-06
Trial ID
NCT02542215
Treatments Being Tested
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
This is a 12-week, randomized, multicenter, double-blind, placebo controlle...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-02
Trial ID
NCT01000493
Treatments Being Tested